Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency

Journal of the American Veterinary Medical Association

Volumn 231, Issue 7, 2007, Pages 1061-1069

  Atkins, Clarke E ^a   Keene, Bruce W ^a   Brown, William A ^b   Coats, Julie R ^a,j   Crawford, Mary Ann ^c   DeFrancesco, Teresa C ^a   Edwards, N Joel ^d,k   Fox, Phillip R ^e   Lehmkuhl, Linda B ^f,l   Luethy, Michael W ^g   Meurs, Kathryn M ^f,m   Petrie, Jean Paul ^e   Pipers, Frank S ^h,j   Rosenthal, Steven L ⁱ   Sidley, Jennifer A ^a,i   Straus, Justin H ^c,n  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b Veterinary Cardiology Consults   (United States)

^c Oradell Animal Hospital   (United States)

^d Capital Region Vet Med Specialties   (United States)

^e ANIMAL MEDICAL CENTER   (United States)

^f OHIO STATE UNIVERSITY   (United States)

^g Cardioscope Pet Referral Service   (United States)

^h BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

ⁱ Chesapeake Veterinary Referral Center   (United States)

^j Upstate Veterinary Specialties ^*  (United States)

^k Upstate Veterinary Specialties   (United States)

^l MedVet Specialty Clinic   (United States)

^m WASHINGTON STATE UNIVERSITY   (United States)

ⁿ Animal Emergency and Referral Center   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

EID: 35548990635     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.231.7.1061     Document Type: Article

References (54)

1. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-1435.
2. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
3. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821-828.
4. Brown NJ, Vaughan DE. Angiotensin-Converting enzyme inhibitors. Circulation 1998;97:1411-1420.
5. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-310.
6. The COVE Study Group. Controlled clinical evaluation of enalapril in dogs with heart failure: results of the Cooperative Veterinary Enalapril Study Group. J Vet Intern Med 1995;9:243-252.
7. Improve Study Group. Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally-acquired heart failure: results of the invasive multi-center prospective veterinary evaluation of enalapril study. J Vet Intern Med 1995;9:234-242.
8. Ettinger SJ, Benitz AM, Ericsson GF, et al. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group. J Am Vet Med Assoc 1998;213:1573-1577.
9. The BENCH Study Group. The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: results of a multi center, prospective, randomized, double-blinded, placebo-controlled, long-term clinical trial. J Vet Cardiol 1999;1:5-18.
10. Amberger C, Chetboul V, Bomassi E, et al. Comparison of the effects of imidapril and enalapril in a prospective, multicentric, randomized trial in dogs with naturally acquired heart failure. J Vet Cardiol 2004;6:9-16.
11. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators. N Engl J Med 1992;327:685-691.
12. Sisson DD, Kvart C, Darke GG. Acquired mitral valvular disease in dogs and cats. In: Fox PR, Sisson DD, Moise NS, eds. Textbook of canine and feline cardiology: principles and clinical practice. Philadelphia: WB Saunders Co, 1999;536-566.
13. Host U, Kelbaek H, Hildebrandt P, et al. Effect of ramipril on mitral regurgitation secondary to mitral valve prolapse. Am J Cardiol 1997;80:655-658.
14. Calabro R, Pisacane C, Pacileo G, et al. Hemodynamic effects of a single oral dose of enalapril among children with asymptomatic chronic mitral regurgitation. Am Heart J 1999;138:955-961.
15. Mori Y, Nakazawa M, Tomimatsu H, et al. Long-term effect of angiotensin-converting enzyme inhibitor in volume overloaded heart during growth: a controlled pilot study. J Am Coll Cardiol 2000;36:270-275.
16. Marcotte F, Honos GN, Walling AD, et al. Effect of angiotensin-converting enzyme inhibitor therapy in mitral regurgitation with normal left ventricular function. Can J Cardiol 1997;13:479-485.
17. Tischler MD, Rowan M, LeWinter MM. Effect of enalapril therapy on left ventricular mass and volumes in asymptomatic chronic, severe mitral regurgitation secondary to mitral valve prolapse. AmJ Cardiol 1998;82:242-245.
18. Shimoyama H, Sabbah HN, Rosman H, et al. Effects of longterm therapy with enalapril on severity of functional mitral regurgitation in dogs with moderate heart failure. J Am Coll Cardiol 1995;25:768-772.
19. Schon HR. Hemodynamic and morphologic changes after longterm angiotensin converting enzyme inhibition in patients with chronic valvular regurgitation. J Hypertens Suppl 1994; 12: S95-S104.
20. Blackford LW, Golden AL, Bright JM, et al. Captopril provides sustained hemodynamic benefits in dogs with experimentally induced mitral regurgitation. Vet Surg 1990;19:237-242.
21. Hamlin RL, Benitz AM, Ericsson GF, et al. Effects of enalapril on exercise tolerance and longevity in dogs with heart failure produced by iatrogenic mitral regurgitation, J Vet Intern Med 1996;10:85-87.
22. Uehara Y, Takahashi M. Hemodynamic changes during administration of drugs for mitral regurgitation in dogs. J Vet Med Sci 1998;60:213-218.
23. Tunaoglu FS, Olgunturk R, Kula S, et al. Effective regurgitant orifice area of rheumatic mitral insufficiency: response to angiotensin converting enzyme inhibitor treatment. Anadolu Kardiyol Derg 2004;4:3-7.
24. Lanas F, Garces E, Eggers G, et al. Comparison of the effects of digoxin or enalapril in the treatment of heart failure due to mitral insufficiency [in Spanish]. Rev Med Chil 1998;126:251-257.
25. Heck I, Schmidt J, Mattern H, et al. Reduction of regurgitation in aortic and mitral insufficiency by Captopril in acute and long-term trials [in German], Schweiz Med Wochenschr 1985;115:1615-1618.
26. Kitagawa H, Wakamiya H, Kitoh K, et al. Efficacy of monotherapy with benazepril, an angiotensin converting enzyme inhibitor, in dogs with naturally acquired chronic mitral insufficiency. J Vet Med Sci 1997;59:513-520.
27. Chockalingam A, Venkatesan S, Dorairajan S, et al. Safety and efficacy of enalapril in multivalvular heart disease with significant mitral stenosis-SCOPE-MS. Angiology 2005;56:151-158.
28. Wisenbaugh T, Sinovich V, Dullabh A, et al. Six month pilot study of Captopril for mildly symptomatic, severe isolated mitral and isolated aortic regurgitation. J Heart Valve Dis 1994;3:197-204.
29. Jirasirirojanakorn K, Mahanonda N, Jootar P, et al. Short-term evaluation of Captopril in patients with chronic left sided valvular regurgitations. J Med Assoc Thai 1998;81:1-9.
30. Dell'italia LJ, Balcells E, Meng QC, et al. Volume-overload cardiac hypertrophy is unaffected by ACE inhibitor treatment in dogs. AmJ Physiol 1997;273:H961-H970.
31. Rothlisberger C, Sareli P, Wisenbaugh T. Comparison of single dose nifedipine and Captopril for chronic severe mitral regurgitation. Am J Cardiol 1994;73:978-981.
32. Nemoto S, Hamawaki M, De Freitas G, et al. Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation. J Am Coll Cardiol 2002;40:149-154.
33. Kvart C, Haggstrom J, Pedersen HD, et al. Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation. J Vet Intern Med 2002;16:80-88.
34. Sabbah HN, Shimoyama H, Kono T, et al. Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction. Circulation 1994;89:2852-2859.
35. Atkins CE, Brown WA, Coats JR, et al. Effects of long-term administration of enalapril on clinical indicators of renal function in dogs with compensated mitral regurgitation. J Am Vet Med Assoc 2002;221:654-658.
36. Dupont WD, Plummer WD Jr, Power and sample size calculations: a review and computer program. Control Clin Trials 1990;11:116-128.
37. Orton EC, Hackett TB, Mama K, et al. Technique and outcome of mitral valve replacement in dogs. J Am Vet Med Assoc 2005;226:1508-1511.
38. Griffiths LG, Orton EC, Boon JA. Evaluation of techniques and outcomes of mitral valve repair in dogs. J Am Vet Med Assoc 2004;224:1941-1945.
39. Tidholm A, Haggstrom J, Hansson K. Effects of dilated cardiomyopathy on the renin-angiotensin-aldosterone system, atrial natriuretic peptide activity, and thyroid hormone concentrations in dogs. Am J Vet Res 2001;62:961-967.
40. Fujii Y, Wakao Y. Spectral analysis of heart rate variability in dogs with mild mitral regurgitation. AmJ Vet Res 2003;64:145-148.
41. Pedersen HD, Koch J, Poulsen K, et al. Activation of the renin-angiotensin system in dogs with asymptomatic and mildly symptomatic mitral valvular insufficiency. J Vet Intern Med 1995;9:328-331.
42. Koch J, Pedersen HD, Jensen AL, et al. Activation of the reninangiotensin system in dogs with asymptomatic and symptomatic dilated cardiomyopathy. Res Vet Sci 1995;59:172-175.
43. Ligtenberg G, Blankestijn PJ, Oey PL, et al. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 1999;340:1321-1328.
44. Swedberg K, Kjekshus J, Snapinn S. Long-term survival in severe heart failure in patients treated with enalapril. Ten year follow-up of CONSENSUS I. Eur Heart J 1999;20:136-139.
45. Beardow AW, Buchanan JW. Chronic mitral valve disease in Cavalier King Charles Spaniels: 95 cases (1987-1991). J Am Vet Med Assoc 1993;203:1023-1029.
46. Pederson HD, Olsen LH, Amorsdottir H. Breed differences in the plasma renin activity and plasma aldosterone concentration of dogs. J Vet Med 1995;42:435-441.
47. Dillon RA. Cardiac remodeling in canine mitral valve volume overload, in Proceedings. 1st Int Canine Valvular Dis Symp 2005; 1:52-59.
48. Perry GJ, Wei CC, Hankes GH, et al. Angiotensin II receptor blockade does not improve left ventricular function and remodeling in subacute mitral regurgitation in the dog. J Am Coll Cardiol 2002;39:1374-1379.
49. Gaasch WH, Aurigemma GP. Inhibition of the renin-angiotensin system and the left ventricular adaptation to mitral regurgitation. J Am Coll Cardiol 2002;39:1380-1383.
50. Coulter DM, Edwards IR. Cough associated with Captopril and enalapril. Br Med J 1987;294:1521-1523.
51. CohnJN, Ziesche S, Smith R, et al. Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group. Circulation 1997;96:856-863.
52. Atkins CE, Rausch WP, Gardner SY, et al. The effect of amlodipine and the combination of amlodipine and enalapril on the renin-angiotensin-aldosterone system in the dog. J Vet Pharmacol Ther 2007;30:394-400.
53. Remme WJ, Riegger G, Hildebrandt P, et al. The benefits of early combination treatment of Carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The Carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN). Cardiovasc Drugs Ther 2004;18:57-66.
54. Lombarde CW, Jons O, Bussadori CM. Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs. J Am Anim Hosp Assoc 2006;42:249-261.